Innate Pharma Stock Quote IPH - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.532

Bid

1.52

Ask

1.576

Volume

37,092

1.52 Day's Range 1.55

1.39 52 Week Range 2.80

Market Cap

487.437M

Previous Close

1.528

Open

1.524

Last Trade

1.532

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

72,133

Shares Outstanding

318,170,508

Dividend Yield

PE Ratio

-64.29

Earnings Per Share (EPS)

-0.02

Revenue

61.64M

Net Profit

-7.57M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IPH. The last closing price for Innate Pharma was 1.53 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.39 € to 2.80 €.

Innate Pharma currently has 318,170,508 shares outstanding. The market capitalization of Innate Pharma is 486.16 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -64.29.

Innate Pharma publie son calendrier financier pour 2025

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») publie aujourd’hui son calendrier financier pour l’année 2025 : 27 mars 2025 : Publication...

Innate Pharma annonce une publication dans la revue Science Immunology mettant en avant le NK cell engager ANKET® de nouvelle génération IPH6501

IPH6501 est un NK Cell Engager tetra-spécifique de nouvelle génération, comprenant un variant de l’IL-2, ciblant CD20 et développé dans les lymphomes non Hodgkiniens à cellules B. IPH6501...

Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results

Jonathan Dickinson appointed Chief Executive Officer and Chairman of the Executive Board Encouraging initial FDA feedback received on lacutamab regulatory pathway Lacutamab health-related...

Innate Pharma annonce les présentations de données de son portefeuille innovant en oncologie sélectionnées pour le congrès annuel du SITC 2024

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que de nouvelles données précliniques soutenant le développement...

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the Company will hold a conference call on Wednesday, November 13, 2024, at...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.012	0.789473684211	1.52	1.64	1.39	144450	1.49339127	DE
4	-0.096	-5.89680589681	1.628	1.744	1.39	91827	1.57626783	DE
12	-0.568	-27.0476190476	2.1	2.19	1.39	72133	1.78610332	DE
26	-1.028	-40.15625	2.56	2.79	1.39	63456	2.01759158	DE
52	-0.753	-32.95404814	2.285	2.8	1.39	75341	2.23798691	DE
156	-2.848	-65.0228310502	4.38	4.84	1.39	144813	2.94192391	DE
260	-3.818	-71.3644859813	5.35	8.3	1.39	274190	4.14551752	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLAAHAmatheon Agri Holding NV	0.02 € (100.00%)	5k
GNROGeNeuro SA	0.0768 € (25.49%)	200
BIDSGascogne DS	0.005 € (25.00%)	150.51k
ALSAFSAFE	0.11 € (23.73%)	39.98k
ALKKOKKO International SA	0.112 € (21.21%)	4.13M
ALIMOGroupimo	0.189 € (-40.94%)	392
MLUMGUmalis Group	1.30 € (-31.22%)	1.71k
MLNMAMiguet Et Associes	0.075 € (-24.62%)	1.72k
MLSEQSequa Petroleum NV	0.008 € (-20.00%)	23k
VACBSPierre & Vacances	0.05 € (-15.25%)	35.99k
BCPBanco Comercial Portugues SA	0.4446 € (-0.49%)	69.24M
ALNEVNeovacs	0.0002 € (0.00%)	41.4M
ALCYBCybergun	0.0001 € (0.00%)	30.32M
INGAING Groep NV	14.652 € (-1.16%)	14.06M
ACACredit Agricole SA	13.05 € (-1.66%)	8.06M